Tower Research Capital (TRC)’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$412K Buy
2,998
+2,268
+311% +$312K 0.01% 1148
2025
Q1
$132K Sell
730
-6,269
-90% -$1.13M ﹤0.01% 1616
2024
Q4
$1.1M Buy
6,999
+6,912
+7,945% +$1.08M 0.02% 581
2024
Q3
$15.8K Sell
87
-2,115
-96% -$385K ﹤0.01% 3394
2024
Q2
$404K Buy
2,202
+565
+35% +$104K 0.01% 1513
2024
Q1
$291K Buy
1,637
+381
+30% +$67.8K 0.01% 1180
2023
Q4
$156K Sell
1,256
-350
-22% -$43.4K ﹤0.01% 2290
2023
Q3
$186K Buy
1,606
+911
+131% +$106K 0.01% 1475
2023
Q2
$81.6K Sell
695
-261
-27% -$30.6K ﹤0.01% 2177
2023
Q1
$77K Buy
956
+571
+148% +$46K ﹤0.01% 2107
2022
Q4
$31K Sell
385
-3,092
-89% -$249K ﹤0.01% 2718
2022
Q3
$242K Buy
3,477
+710
+26% +$49.4K ﹤0.01% 1732
2022
Q2
$181K Sell
2,767
-359
-11% -$23.5K ﹤0.01% 1838
2022
Q1
$208K Sell
3,126
-2,473
-44% -$165K ﹤0.01% 1689
2021
Q4
$391K Buy
5,599
+3,189
+132% +$223K 0.01% 1282
2021
Q3
$126K Buy
2,410
+558
+30% +$29.2K ﹤0.01% 2204
2021
Q2
$126K Buy
1,852
+734
+66% +$49.9K ﹤0.01% 2235
2021
Q1
$87K Buy
1,118
+474
+74% +$36.9K ﹤0.01% 2691
2020
Q4
$39K Buy
644
+321
+99% +$19.4K ﹤0.01% 3344
2020
Q3
$14K Sell
323
-3,349
-91% -$145K ﹤0.01% 3964
2020
Q2
$152K Buy
+3,672
New +$152K 0.01% 2057
2020
Q1
Sell
-1,180
Closed -$65K 3506
2019
Q4
$65K Buy
1,180
+497
+73% +$27.4K 0.01% 1173
2019
Q3
$23K Sell
683
-1,112
-62% -$37.4K ﹤0.01% 2372
2019
Q2
$72K Buy
+1,795
New +$72K ﹤0.01% 1360
2019
Q1
Sell
-1,140
Closed -$24K 4053
2018
Q4
$24K Sell
1,140
-1,487
-57% -$31.3K ﹤0.01% 1794
2018
Q3
$46K Buy
+2,627
New +$46K ﹤0.01% 1804